PG 3000 Photographic Digital Printer from FUJIFILM Life Science
...se Cytokine Array is a multiplex sandwich ELISA (e...tive measurement of 12 cytokines in serum; EDTA, h...ants. Each well of the microplate provided is spot...s in standards and samples added to the plate. Aft...
... fast and simple integration of FRT-sites into lar...tion of transgenic mouse models). The included FRT...mycin / kanamycin selection in prokaryotic and euk...(gb2) for expression of kanamycin resistance in E...
Agencourt AMPure 60ml Kit from Agencourt Bioscience
Biology Products:(Date:11/24/2009)... Ambassador to also Visit Detroit , ...David Appia, French Ambassador for International I...rance Agency, , , , ,What: Ambassador Appia is av...usiness initiatives adopted by France to further d...e for innovation and development., , ,When: Availa...
(Date:11/24/2009)... Nov. 24 Sigma-Aldrich C...the NASDAQ OMX conference on Tuesday, December 1st...ted parties may listen via live audio broadcast ov....sig m a a ldrich.com/ . Users can click the...ut Sigma-Aldrich: Sigma-Aldrich is a leading Lif...
(Date:11/24/2009)...GHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolax...nistration (SFDA) has approved the,investigational...roject,(Nodlin), an innovative insulin formulation...xy to initiate its first phase I clinical study. ,... high blood glucose and poor,metabolism. The compl...
(Date:11/24/2009)...November 24 Shire plc (L...opharmaceutical company, today,announced that it h...y for,velaglucerase alfa, the company,s enzyme rep...of Type 1 Gaucher disease. This is the third marke...een submitted, with previous,submissions in the Un...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4